Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.42 |
| ▸ | TOP1 | P11387 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 3/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
| ▸ | CA2 | P00918 | 1/20 | 0.30 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.30 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30864436 | 1.00 | ALDH1A1 (0.42) | ALDH1A1TOP1LMNATDP1CYP3A4 | |
| SCHEMBL21144801 | 0.87 | ALDH1A1 (0.48) | ALDH1A1TOP1LMNATDP1CYP3A4 | |
| SCHEMBL21166524 | 0.83 | ALDH1A1 (0.43) | ALDH1A1LMNATDP1CYP3A4TSHR | |
| SCHEMBL21171932 | 0.83 | TSHR (0.36) | ALDH1A1TOP1LMNATDP1TSHR | |
| SCHEMBL30592702 | 0.77 | ALDH1A1 (0.55) | ALDH1A1LMNATDP1CYP3A4TSHR | |
| SCHEMBL13067633 | 0.77 | LMNA (0.44) | ALDH1A1TOP1LMNATDP1L3MBTL1 | |
| SCHEMBL21171928 | 0.77 | LMNA (0.43) | ALDH1A1TOP1LMNATDP1CYP3A4 | |
| SCHEMBL21142987 | 0.73 | ALDH1A1 (0.43) | ALDH1A1LMNATDP1CYP3A4TSHR | |
| SCHEMBL16871884 | 0.73 | ALDH1A1 (0.64) | ALDH1A1LMNATDP1CYP3A4TSHR | |
| SCHEMBL21901457 | 0.73 | LMNA (0.58) | TOP1LMNATDP1L3MBTL1KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3737662-A1 | BRANCHED TRIALKYLAMINE PRECURSORS, INTERMEDIATES, PRODUCTS MADE THEREFROM AND PROCESSES OF MANUFACTURE | Eastman Chemical Company (US) | 2020-11-18 | — | — | EP | disclosed |
| CN-111601786-A | Branched trialkylamine precursors, intermediates, products made therefrom, and methods of making | 伊士曼化工公司 | 2020-08-28 | — | — | CN | disclosed |
| US-20190218170-A1 | BRANCHED TRIALKYLAMINE PRECURSORS, INTERMEDIATES, PRODUCTS MADE THEREFROM AND PROCESSES OF MANUFACTURE | EASTMAN CHEMICAL COMPANY (US) | 2019-07-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190218170-A1 | BRANCHED TRIALKYLAMINE PRECURSORS, INTERMEDIATES, PRODUCTS MADE THEREFROM AND PROCESSES OF MANUFACTURE | ACADM, ALK, FASN | ALDH1A1 1105/4885TOP1 3871/4885LMNA 388/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.